Today: 9 July 2026
Browse Category

Financial Forecasts 24 December 2025 - 25 December 2025

Diageo plc Stock (DGE.L, DEO) Near 52‑Week Lows on Dec. 25, 2025: Latest News, Analyst Forecasts, and What to Watch in 2026

Diageo plc Stock (DGE.L, DEO) Near 52‑Week Lows on Dec. 25, 2025: Latest News, Analyst Forecasts, and What to Watch in 2026

LONDON / NEW YORK — December 25, 2025 — Diageo plc, the spirits giant behind Guinness, Johnnie Walker and Don Julio, heads into the year-end holiday period with its shares hovering near fresh 52‑week lows. With the London Stock Exchange closed for Christmas and U.S. markets also shut, the latest available pricing still underscores the same story: investors are weighing a slowing global spirits cycle against a leadership reset and a renewed push to strengthen the balance sheet.
25 December 2025
···
Shell Plc (SHEL) Stock News on Dec. 25, 2025: Buybacks, Gulf Discovery, and 2026 Forecasts in Focus

Shell Plc (SHEL) Stock News on Dec. 25, 2025: Buybacks, Gulf Discovery, and 2026 Forecasts in Focus

December 25, 2025 — With U.S. and UK markets shut for Christmas Day, Shell Plc stock heads into the holiday pause with investors digesting a dense bundle of late-December headlines: a fresh U.S. Gulf of Mexico oil discovery near existing Shell infrastructure, ongoing daily buyback disclosures under a $3.5 billion program, and a pipeline of strategic and regulatory developments stretching from Germany to southern Africa.
25 December 2025
··
Salesforce (CRM) Stock After the Bell on Dec. 24, 2025: Today’s Price Action, Fresh Forecasts, and What to Know Before the Next Market Open

Salesforce (CRM) Stock After the Bell on Dec. 24, 2025: Today’s Price Action, Fresh Forecasts, and What to Know Before the Next Market Open

NEW YORK — Dec. 24, 2025 — Salesforce, Inc. ended the holiday-shortened Christmas Eve session higher, tracking a broadly upbeat tape that pushed major U.S. indexes to fresh milestones. But with trading volume typically thin into year-end—and with U.S. markets closed on Thursday, Dec. 25—investors are now shifting their focus to what matters most for the next open: whether Salesforce’s Agentforce-led AI push keeps translating into durable bookings, clearer monetization, and steadier growth acceleration in 2026. AP News+2Salesforce Investor Relations+2
24 December 2025
···
Regencell Bioscience Holdings (NASDAQ: RGC) Stock News Today: Price Action, DOJ Probe Overhang, and the Latest Forecasts on Dec. 24, 2025

Regencell Bioscience Holdings (NASDAQ: RGC) Stock News Today: Price Action, DOJ Probe Overhang, and the Latest Forecasts on Dec. 24, 2025

Dec. 24, 2025 — Regencell Bioscience Holdings Limited is once again reminding markets that “biotech stock” plus “low float” can equal “physics optional.” By the close of trading on December 24, RGC finished at $24.60, down 2.57% from the prior close of $25.25, after trading between $24.60 and $26.42 on the day, with roughly 348K shares traded. StockAnalysis+1
24 December 2025
·
Micron Technology (MU) Stock Hits Fresh Records on Dec. 24, 2025: AI Memory Crunch, Blowout Guidance, and Wall Street’s Latest Forecasts

Micron Technology (MU) Stock Hits Fresh Records on Dec. 24, 2025: AI Memory Crunch, Blowout Guidance, and Wall Street’s Latest Forecasts

Micron Technology, Inc. is closing out Christmas Eve trading in full “Santa rally” fashion. In the holiday-shortened U.S. session on December 24, 2025, Micron climbed to a record high and helped lift broader market sentiment as investors continued to reprice the company around one big theme: AI data centers are turning memory into the new choke point. Reuters
24 December 2025
···
GE Vernova Stock (NYSE: GEV) News on Dec. 24, 2025: AI Power Demand, Raised 2026–2028 Outlook, and Wall Street’s Latest Targets

GE Vernova Stock (NYSE: GEV) News on Dec. 24, 2025: AI Power Demand, Raised 2026–2028 Outlook, and Wall Street’s Latest Targets

December 24, 2025 — GE Vernova Inc. has become one of the market’s most closely watched “power for AI” stocks in 2025, and Christmas Eve trading is arriving with the shares still in the spotlight after a dramatic two-week stretch of upgrades, volatility, and fresh contract headlines.
24 December 2025
···
Rocket Lab (RKLB) Stock News Today: $816M Space Force Contract, Needham Raises Price Target to $90, and 2026 Forecasts

Rocket Lab (RKLB) Stock News Today: $816M Space Force Contract, Needham Raises Price Target to $90, and 2026 Forecasts

December 24, 2025 — Rocket Lab Corporation stock is spending Christmas Eve doing what overheated momentum names often do: pausing and digesting. After a blistering December rally fueled by defense-contract news and a record-setting launch cadence, RKLB shares traded in the mid-$70s in the shortened U.S. session, slipping modestly as investors weigh how much of 2026’s growth is already priced in. MarketBeat+1
24 December 2025
····
Tesla Stock Today (Dec. 24, 2025): TSLA Near $485 as NHTSA Probe, Delivery Forecasts and Robotaxi Bets Drive the Outlook

Tesla Stock Today (Dec. 24, 2025): TSLA Near $485 as NHTSA Probe, Delivery Forecasts and Robotaxi Bets Drive the Outlook

Tesla, Inc. is heading into the Christmas Eve session with its stock price hovering just below a psychologically important threshold: $500. That near-round-number “gravity” isn’t just trader superstition—it’s where valuation debates, delivery forecasts, and autonomy optimism collide for one of the market’s most narrative-driven mega-caps.
24 December 2025
···
Netflix Stock (NFLX) News and Forecast on Dec. 24, 2025: Warner Bros Deal Financing, Analyst Targets, and What Investors Are Watching

Netflix Stock (NFLX) News and Forecast on Dec. 24, 2025: Warner Bros Deal Financing, Analyst Targets, and What Investors Are Watching

Netflix, Inc. is trading through a shortened Christmas Eve session with Wall Street focused on one story above all others: the company’s blockbuster bid to acquire Warner Bros.’ studios and streaming assets—and the fast-moving financing, regulatory, and competitive dynamics around it. New York Stock Exchange+2Netflix+2
24 December 2025
··
Novo Nordisk Stock (NVO) in Focus on Dec. 24, 2025: Wegovy Pill Shockwave, Policy Tailwinds, and Analyst Forecasts

Novo Nordisk Stock (NVO) in Focus on Dec. 24, 2025: Wegovy Pill Shockwave, Policy Tailwinds, and Analyst Forecasts

Dec. 24, 2025 — Novo Nordisk A/S has snapped back into the market’s spotlight this week after U.S. regulators cleared a pill version of its blockbuster obesity drug Wegovy—an approval that investors and analysts see as a pivotal moment in the fast-evolving GLP‑1 weight-loss race. But the story driving Novo Nordisk stock today is bigger than a single FDA decision: it’s also about pricing and coverage policy in the U.S., and a global expansion battle—especially in India—where branded GLP‑1s are colliding with the prospect of cheaper generics in 2026. Novo Nordisk+2Reuters+2
24 December 2025
···
Broadcom (AVGO) Stock News Today, Forecasts and Analysis for Dec. 24, 2025: AI Margins, Tariffs, Insider Moves and Valuation

Broadcom (AVGO) Stock News Today, Forecasts and Analysis for Dec. 24, 2025: AI Margins, Tariffs, Insider Moves and Valuation

Broadcom Inc. enters Christmas Eve trading with investors still debating the same two questions that have defined the stock’s volatile December: how durable is the AI-driven demand surge—and how much profitability gets sacrificed to capture it? With U.S. equities markets scheduled to close early at 1:00 p.m. ET today, liquidity is thinner than usual, which can exaggerate moves in high-momentum names like Broadcom. New York Stock Exchange+1
24 December 2025
··
Rezolute, Inc. (RZLT) Stock News and Forecasts on Dec. 24, 2025: Phase 3 sunRIZE Miss, Analyst Target Cuts, and What Comes Next

Rezolute, Inc. (RZLT) Stock News and Forecasts on Dec. 24, 2025: Phase 3 sunRIZE Miss, Analyst Target Cuts, and What Comes Next

Rezolute, Inc. is still in the spotlight on December 24, 2025, after a brutal mid-December selloff tied to its pivotal clinical trial news—and a wave of follow-on analyst downgrades, price-target resets, and investor-law-firm investigations. As of the latest available pricing around $2.42 per share, the stock is off its post-trial lows but remains dramatically below pre-readout levels, leaving investors weighing a simple question with complicated consequences: was sunRIZE a fatal blow, or a detour that shifts the story toward Rezolute’s next late-stage program? MarketBeat+1
24 December 2025
··
Reviva Pharmaceuticals (RVPH) Stock Plunges After FDA Calls for Second Phase 3 Trial: News, Forecasts, and Analyst Takeaways on Dec. 24, 2025

Reviva Pharmaceuticals (RVPH) Stock Plunges After FDA Calls for Second Phase 3 Trial: News, Forecasts, and Analyst Takeaways on Dec. 24, 2025

Reviva Pharmaceuticals Holdings, Inc. is in the spotlight on December 24, 2025 after a sharp selloff driven by a major regulatory development: the U.S. Food and Drug Administration recommended that Reviva run an additional Phase 3 trial for its lead schizophrenia candidate, brilaroxazine, before filing a New Drug Application. SEC+1
24 December 2025
···
1 … 3 4 5 6 7 … 42

Stock Market Today

  • Tasmea MD Stephen Young picks up AU$500k in shares at AU$8.99
    July 9, 2026, 5:07 PM EDT. Tasmea Limited (ASX:TEA) boss Stephen Young just bought AU$500,000 of stock at AU$8.99 a share, following up on his AU$1 million purchase earlier this year at AU$4.50. Insiders haven't sold any shares in the past year and still own 45% of the company, or about AU$1 billion worth. The buying came as shares moved higher. Investors could see the insider activity as a sign management is backing Tasmea's outlook, with interests lined up with shareholders.
Go toTop